Author

M. Chu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Approach:statistical model· 2 Organism:bacteria (other)· 1 Approach:biophysical modeling· 1

Frequent Co-Authors

J. Huang· 2 shared Y. Li· 2 shared Y. Wang· 2 shared A. Toth· 1 shared A.-M. Dragoi· 1 shared B. Du· 1 shared C. Abshire· 1 shared C. Latario· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Huang

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Dual role of CASP8AP2/FLASH in regulating epithelial-to-mesenchymal (EMT) plasticity

M. Catalanotto, J. M. Vaz, C. Abshire, R. Youngblood, M. Chu, H. Levine, M. K. Jolly, A.-M. Dragoi

This study identifies FLASH as a regulator of EMT plasticity, showing it influences hybrid E/M states through its effects on EMT-TFs and cell junction proteins.

bioRxiv · Mar 12, 2023 · PreprintCancer Biology

Multi-omics analysis combining pyroptosis-related signatures for building a prognosis prediction model in hepatocellular carcinoma

J. Huang, Y. Li, M. Chu, Y. Wang

This study builds a 22-gene prognosis model for hepatocellular carcinoma using pyroptosis-related signatures, showing low-risk patients have significantly better survival.

bioRxiv · Jan 24, 2022 · PreprintCancer Biology

Tuftsin: a natural molecule against SARS-CoV-2 infection

J. Huang, J. Wang, Z. Wang, M. Chu, Y. Wang

The paper identifies tuftsin as a natural human molecule that targets ACE2 and NRP1, impairing SARS-CoV-2 infection and suggesting its potential as a therapeutic for COVID-19.

bioRxiv · Jan 10, 2022Immunology

Directed evolution reveals the mechanism of HitRS signal transduction in Bacillus anthracis

E. P. Skaar, H. Pi, M. Chu, S. Ivan, C. Latario, A. Toth, S. Carlin, G. Hillebrand, H. Lin, J. Reppart, D. L. Stauff

This study uses genetic selections to uncover the molecular mechanism of the HitRS signal transduction system in Bacillus anthracis, identifying key residues and interactions essential for TCS function.

bioRxiv · Jul 3, 2020Biochemistry

Cross-neutralization antibodies against SARS-CoV-2 and RBD mutations from convalescent patient antibody libraries

Y. Lou, W. Zhao, H. Wei, M. Chu, R. Chao, H. Yao, J. Su, Y. Li, X. Li, Y. Cao, Y. Feng, P. Wang, Y. Xia, Y. Shang, F. Li, , M. Liu

bioRxiv · Jun 6, 2020 · PreprintImmunology